New Multi-Center Study Shows equicenta® CTM, Ready-to-Use, Equine Umbilical Cord Allograft Outperforms Standard of Care in Returning Performance Horses to Work

AUSTIN, Texas--(BUSINESS WIRE)--Equine Performance Labs (EPL), the team behind equicenta® CTM — announced the publication of a peer-reviewed, prospective, controlled clinical trial demonstrating that a single, ready-to-use injection of equicenta® CTM produced significantly better clinical outcomes than clinician-selected standard of care (SOC) in lame performance horses. The study was accepted June 29, 2026 in Frontiers in Veterinary Science (Veterinary Regenerative Medicine section) and repres